Outset Medical (OM) Cash from Investing Activities (2019 - 2026)

Outset Medical (OM) has 8 years of Cash from Investing Activities data on file, last reported at $7.9 million in Q1 2026.

• On a quarterly basis, Cash from Investing Activities rose 110.12% year-over-year to $7.9 million in Q1 2026; TTM through Mar 2026 was -$11.7 million, a 113.79% decrease from a year earlier, with the FY2025 full-year figure at -$97.7 million, down 193.98% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $7.9 million, down from $8.6 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for OM reached as high as $108.2 million in Q4 2024 and fell as low as -$78.1 million in Q1 2025.
• Historically, Cash from Investing Activities has averaged $1.8 million across 5 years, with a median of $7.9 million in 2026.
• Across the five-year window, Cash from Investing Activities soared 2163.3% in 2023 and sank 2333.48% in 2024, its largest moves.
• Year by year, Cash from Investing Activities stood at -$51.7 million in 2022, then surged by 145.27% to $23.4 million in 2023, then soared by 361.7% to $108.2 million in 2024, then slumped by 92.06% to $8.6 million in 2025, then retreated by 8.04% to $7.9 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $7.9 million in Q1 2026, $8.6 million in Q4 2025, and $3.0 million in Q3 2025.